M&T Bank Corp Royalty Pharma PLC Transaction History
M&T Bank Corp
- $30.1 Billion
- Q3 2024
A detailed history of M&T Bank Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, M&T Bank Corp holds 18,749 shares of RPRX stock, worth $598,843. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,749
Previous 18,749
-0.0%
Holding current value
$598,843
Previous $530,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RPRX
# of Institutions
411Shares Held
284MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.31 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$735 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$515 Million0.35% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$389 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...